Amine-Based Matriptase 2 Inhibitors for Hepcidin Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for iron-refractory iron deficiency anemia (IRIDA) lack effective modulators to inhibit Matriptase-2 activity, which is crucial for regulating hepcidin production and iron metabolism.
Innovation Solution
Development of specific compounds, such as those represented by Formula I, which act as Matriptase 2 inhibitors, to treat disorders associated with relative or absolute hepcidin deficiency by increasing hepcidin production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Matriptase-2 activity is inhibited, then hepcidin production increases, but current treatments lack effective modulators to achieve this inhibition
Solution Approach 1:
The patent employs parameter changes by systematically varying molecular structures of compounds (Formula I, IV, VIV-a) to optimize Matriptase-2 inhibition. By modifying chemical parameters such as substituent groups, ring structures, and molecular weight, the invention achieves reliable hepcidin production regulation while addressing the lack of effective modulators
Solution Approach 2:
The patent develops composite chemical structures combining multiple functional groups (amine-based core with various aromatic and heterocyclic substituents) to create compounds with enhanced Matriptase-2 inhibitory activity. These composite molecular structures provide both the reliability of consistent inhibition and the versatility needed for effective treatment
2Quantity of substance
If matriptase-2 activity is lost or inhibited, then hepcidin production increases, but no effective therapeutic agents are available
Solution Approach 1:
The patent segments the molecular structure into distinct functional components: a core amine-based structure (Formula I) with variable substituent groups (R1-R10, Ar, L1-L3). This segmentation allows systematic optimization of hepcidin production stimulation while simplifying the manufacturing process through modular synthesis approaches
Solution Approach 2:
By changing chemical parameters of the compound structure (molecular weight, lipophilicity, substituent types), the patent achieves both increased hepcidin production and improved ease of manufacture through standardized pharmaceutical synthesis protocols
Data Source
AI summary
The present disclosure provides amine based compounds for inhibiting matriptase 2, or a mutant thereof, and compositions and methods of use thereof.